Areas of Focus
- Medical applications of nanotechnology
- Development of tumor-targeting molecules
Work Experience
- Postdoctoral Researcher - Stanford University
- Scientist - Roche Pharmaceuticals
- Medical Director Asia-Pacific - Pharmacia
- Attending Physician - San Jose Medical Center
Academic Background & Achievements
- Medical Doctor: Peking Union Medical College
- Ph.D. in Science: State University of New York
- Published in Nature journal
Publications
- Carbon Nanotubes Enhance Cytotoxicity Mediated by Human Lymphocytes, Sun Zhao, Liu Zhe, Meng Jie, Meng Jie, Duan Jinhong, Xie Sishen, Lu Xin, Zhu Zhaohui, Wang Chen, Shuchang, Xu Haiyan, Yang Xian-Da, 2011
- Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells, Chenchen Yu, Yan Hu, Jinhong Duan, Xianda Yang, 2011
- Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells, Liu Zhe, Jinhong Duan, YongMei Song, Jie Ma, Fengda Wang, Xin Lu, Xian-Da Yang, 2012
- Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells, Yan Hu, Jinhong Duan, Qimin Zhan, FengDan Wang, Xin Lu, Xian-Da Yang, 2012
- Enhancement of DC-mediated anti-leukemic immunity in vitro by WT1 antigen and CpG co-encapsulated in PLGA microparticles, Liang Zhang, Sun Zhao, Jinhong Duan, Ning Gu, Haiyan Xu, Xian-da Yang, 2013
- Selection of a Novel DNA Aptamer for Assay of Intracellular Interferon-Gamma, Beibei Cao, Yan Hu, Jinhong Duan, Jie Ma, Danke Xu, Xian-Da Yang, 2014
- In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide, Wei Wang, Zhongjun Li, Jinhong Duan, Chen Wang, Ying Fang, and Xian-Da Yang, 2014
- A Novel Approach of Targeted Immunotherapy against Adenocarcinoma Cells with Nanoparticles Modified by CD16 and MUC1 Aptamers, Lianyuan Yu, Yan Hu, Jinhong Duan, and Xian-Da Yang, 2015
- Selection of a Novel DNA Thioaptamer against HER2 Structure, Hu Yan, J Duan, B Cao, L Zhang, X Lu, Xian-Da Yang, 2015
- Enhancement of Thermal Damage to AdenocarcinomaCells by Iron Nanoparticles Modified with MUC1 Aptamer, Guo Fangqin, Y Hu, L Yu, X Deng, J Meng, Xian-Da Yang, 2016
- Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for muc1-expressing breast cancer cells, Dai Bindong, Hu yan, Duan Jinhong, Yang xianda, 2016
- Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells, Meng Jie, Fangqin Guo, Haiyan Xu, Wei Liang, Chen Wang, Xian-Da Yang, 2016
